GLG LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 12 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GLG LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$2,331,000
-6.0%
4,960,0000.0%0.15%
-0.7%
Q2 2017$2,480,000
+1.1%
4,960,000
+11.2%
0.15%
+12.6%
Q1 2017$2,453,000
+67.1%
4,460,000
-18.9%
0.14%
+33.7%
Q4 2016$1,468,0005,500,0000.10%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
BVF INC/IL 10,000,000$5,025,0000.78%
GLG LLC 4,960,000$2,480,0000.15%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 7,500,000$3,000,000,0000.05%
View complete list of OREXIGEN THERAPEUTICS INC shareholders